Chemosensitivity testing of fresh and continuous tumor cell cultures using lactate dehydrogenase

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 231-236

  Coley, Helen M ^a   Lewandowicz, Grazyna ^a,b   Sargent, Jean M ^a,b   Verrill, Mark W ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b Pembury Hospital   (United Kingdom)

Author keywords

Chemosensitivity testing; Lactate dehydrogenase; Tumor cell cultures

Indexed keywords

4 HYDROPEROXYIFOSFAMIDE; CISPLATIN; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FORMAZAN; LACTATE DEHYDROGENASE; MAFOSFAMIDE; MELPHALAN;

ARTICLE; CELL COUNT; CHEMOSENSITIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEIOMYOSARCOMA; LEUKEMIA; METHODOLOGY; OVARY CANCER; PRIORITY JOURNAL; RELIABILITY; SARCOMA; SYNOVIOCYTE; TITRIMETRY; TUMOR CELL CULTURE;

CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; L-LACTATE DEHYDROGENASE; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0031049773     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alexander RB, Nelson WG and Coffey DS: Synergistic enhancement by tumour necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II. Cancer Res 47: 2403-2406, 1987.
2. Finlay GJ, Baguley BC and Wilson WR: A semiautomuted microculture method for investigating growth inhibitory effects of cytotoxic compounds on experimentally growing carcinoma cells. Annals Biochem 139: 272-277, 1984.
3. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immun Meth 65: 55-63, 1983.
4. Einsphar J, Alberts DS, Gleason M, Dalton WS and Leibovitz A: Pharmacological pitfalls in the use of the MTT (versus human tumour clonogenic-HTCA) assay to quantitate chemosensitivity of human tumour cell lines. Proc Am Assoc Cancer Res 29: 492, 1988.
5. Finlay GJ, Wilson WR and Baguley BC: Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines. Eur J Cancer Clin Oncol 22: 655-662, 1986.
6. Plumb JA, Milroy R and Kaye SB: effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 49: 4435-4440, 1989.
7. Jabbar SAB, Twentyman PR and Watson JV: The MTT assay underestimates the growth inhibitory effects of interferons. Br J Cancer 60: 523-528, 1989.
8. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Yistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
9. Weisenthal LM and Lippman ME: Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat Rep 69: 615-632, 1985.
10. Hongo T, Fujii Y and Igarashi Y: An in vitro chemosensitivity test for the screening of anticancer drugs in childhood leukaemia. Cancer 65: 1263-1272, 1990.
11. Santini V, Bernabei PA, Silvestro L, Dal Pozzi O, Bezzini R, Viano I, Gattei V, Saccardi R and Rossi Ferrini P: In vitro chemosensitivity testing of leukaemia cells; prediction of response to chemotherapy in patients with acute ono-lymphocytic leukaemia. Haematol Oncol 7: 287-293, 1989.
12. Sargent JM and Taylor CG: Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer 60: 206-210, 1989.
13. Kanematsu T, Maehara Y, Kusumoto T and Sugimachi K: Sensitivity to six antitumour drugs differs between primary and metastatic liver cancers. Eur J Cancer Clin Oncol 24: 1511-1513, 1988.
14. Maehara Y, Kohnoe S and Sugimachi K: Chemosensitivity test for carcinoma of digestive organs. Semin Surg Oncol 6: 42-47, 1990.
15. Wilson IK, Sargent JM, Elgie AW, Hill JG and Taylor CG: A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy. Br J Cancer 62: 189-194, 1940.
16. Sonobe H, Manabe Y, Furihata M, Iwata J, Oka T, Ohtsuki Y, Mizobuchi H, Yamumoto H, Kumano O and Abo S: Establishment and characterisation of a new human synovial sarcoma cell line, HS-SY-11. Lab Invest 67: 498-505, 1992.
17. Twentyman PR and Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56: 279-285, 1987.
18. Korzeniewski C and Callewaert DM: An enzyme-release assay for natural cytotoxicity. J Immun Methods 64: 313-320, 1983.
19. Decker T and Lohmann-Matthes M-L: A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumour necrosis factor (TNF) activity. J Immun Methods 15: 61-69, 1988.
20. Lappalainen K, Jaaskelainen I, Syrjana K, Urtii A and Syrjanen S: Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res 11: 1127-1131, 1994.
21. Sargent JM, Elgie AW, Taylor CG, Wilson JK, Alton P and Hill JG: The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay. In: Chemosensitivity testing in gynaecological malignancies and breast cancer. Contrib Gynecol Obst (Kochli OR and Haller SBU, eds). Karger, 1994, vol 19, pp 64-75.
22. Pieters R, Huismans DR, Leyva A and Veerman AJP: Comparison of the rapid automated MTT assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia. Br J Cancer 59; 217-220, 1989.